Olga Borges

2.7k total citations
65 papers, 2.1k citations indexed

About

Olga Borges is a scholar working on Immunology, Molecular Biology and Pharmaceutical Science. According to data from OpenAlex, Olga Borges has authored 65 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Immunology, 21 papers in Molecular Biology and 20 papers in Pharmaceutical Science. Recurrent topics in Olga Borges's work include Immunotherapy and Immune Responses (21 papers), Advanced Drug Delivery Systems (18 papers) and RNA Interference and Gene Delivery (16 papers). Olga Borges is often cited by papers focused on Immunotherapy and Immune Responses (21 papers), Advanced Drug Delivery Systems (18 papers) and RNA Interference and Gene Delivery (16 papers). Olga Borges collaborates with scholars based in Portugal, Switzerland and Brazil. Olga Borges's co-authors include Gerrit Borchard, Sandra Jesus, Hans E. Junginger, Adriano de Sousa, Edna Soares, Anabela Cordeiro‐da‐Silva, Filipa Lebre, J. Coos Verhoef, Joana Tavares and Mélanie Schmutz and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Journal of Controlled Release.

In The Last Decade

Olga Borges

63 papers receiving 2.0k citations

Peers

Countries citing papers authored by Olga Borges

Since Specialization

Citations

This map shows the geographic impact of Olga Borges's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olga Borges with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olga Borges more than expected).

Fields of papers citing papers by Olga Borges

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olga Borges. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olga Borges. The network helps show where Olga Borges may publish in the future.

Co-authorship network of co-authors of Olga Borges

This figure shows the co-authorship network connecting the top 25 collaborators of Olga Borges. A scholar is included among the top collaborators of Olga Borges based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olga Borges. Olga Borges is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Optimizing mucosal vaccination: Exploiting Lactobionic acid-modified chitosan for superior gene delivery systems 2025 ·International Journal of Biological Macromolecules ·(unknown), (unknown), Maria Teresa Cruz, Luís Pereira de Almeida, Olga Borges	0
2	Optimizing insulin therapy: Are microneedles a viable alternative to subcutaneous insulin injection? 2024 ·Journal of Drug Delivery Science and Technology ·(unknown), Sandra Jesus, Olga Borges	2
3	Exploring the immunomodulatory properties of glucan particles in human primary cells 2024 ·International Journal of Pharmaceutics ·Sandra Jesus, (unknown), (unknown), Filipa Lebre, (unknown), (unknown), Maria Teresa Cruz, Ernesto Alfaro‐Moreno, Olga Borges	6
4	Synthetic and Natural Polymeric Drug Delivery Systems - A Comprehensive Overview of Polycaprolactone and Glucan Particles 2023 ·Journal of biomimetics, biomaterials and biomedical engineering ·(unknown), Sandra Jesus, Olga Borges	1
5	Endotoxin contamination of nanoparticle formulations: A concern in vaccine adjuvant mechanistic studies 2023 ·Vaccine ·(unknown), Sandra Jesus, (unknown), (unknown), Edna Soares, Olga Borges	7
6	A Methodological Safe-by-Design Approach for the Development of Nanomedicines 2020 ·Frontiers in Bioengineering and Biotechnology ·Mélanie Schmutz, Olga Borges, Sandra Jesus, Gerrit Borchard, Giuseppe Perale, Manfred Zinn, (unknown), Lya G. Soeteman‐Hernández, Peter Wick, Claudia Som	49
7	Chitosan-coated PLGA nanoparticles for the nasal delivery of ropinirole hydrochloride: In vitro and ex vivo evaluation of efficacy and safety 2020 ·International Journal of Pharmaceutics ·(unknown), Sandra Jesus, Christina Karavasili, Dimitrios Andreadis, Dimitrios G. Fatouros, Olga Borges	97
8	Chitosan Plus Compound 48/80: Formulation and Preliminary Evaluation as a Hepatitis B Vaccine Adjuvant 2019 ·Pharmaceutics ·(unknown), Sandra Jesus, Filipa Lebre, Teresa Gonçalves, Olga Borges	32
9	Activity and Cell-Death Pathway in Leishmania infantum Induced by Sugiol: Vectorization Using Yeast Cell Wall Particles Obtained From Saccharomyces cerevisiae 2019 ·Frontiers in Cellular and Infection Microbiology ·Débora B. Scariot, Hélito Volpato, (unknown), Edna Soares, Tânia Ueda‐Nakamura, Benedito Prado Dias Filho, Zia Ud Din, Edson Rodrigues‐Filho, Adley F. Rubira, Olga Borges, Maria do Céu Sousa, Celso Vataru Nakamura	24
10	The Inclusion of Chitosan in Poly-ε-caprolactone Nanoparticles: Impact on the Delivery System Characteristics and on the Adsorbed Ovalbumin Secondary Structure 2017 ·AAPS PharmSciTech ·Sandra Jesus, Elizângela H. Fragal, Adley F. Rubira, Edvani C. Muniz, Artur J. M. Valente, Olga Borges	15
11	Immune response elicited by an intranasally delivered HBsAg low-dose adsorbed to poly-ε-caprolactone based nanoparticles 2016 ·International Journal of Pharmaceutics ·Sandra Jesus, Edna Soares, (unknown), Gerrit Borchard, Olga Borges	38
12	Nasal Vaccines Against Hepatitis B: An Update 2015 ·Current Pharmaceutical Biotechnology ·Mariana Rodrigues de Almeida, Olga Borges	7
13	Validation of a New 96-Well Plate Spectrophotometric Method for the Quantification of Compound 48/80 Associated with Particles 2013 ·AAPS PharmSciTech ·(unknown), Gerrit Borchard, Teresa Gonçalves, Olga Borges	6
14	Recent Developments in the Nasal Immunization against Anthrax 2011 ·Sandra Jesus, Olga Borges	6
15	Progress Towards a Needle-Free Hepatitis B Vaccine 2010 ·Pharmaceutical Research ·Filipa Lebre, Gerrit Borchard, Maria C. Pedroso de Lima, Olga Borges	14
16	Mucosal Vaccines: Recent Progress in Understanding the Natural Barriers 2009 ·Pharmaceutical Research ·Olga Borges, Filipa Lebre, (unknown), Gerrit Borchard, Hans E. Junginger	62
17	Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles 2008 ·European Journal of Pharmaceutics and Biopharmaceutics ·Olga Borges, Anabela Cordeiro‐da‐Silva, Joana Tavares, Nuno Santarém, Adriano de Sousa, Gerrit Borchard, Hans E. Junginger	121
18	Alginate coated chitosan nanoparticles are an effective subcutaneous adjuvant for hepatitis B surface antigen 2008 ·International Immunopharmacology ·Olga Borges, (unknown), Adriano de Sousa, Gerrit Borchard, Hans E. Junginger, Anabela Cordeiro‐da‐Silva	83
19	Evaluation of the immune response following a short oral vaccination schedule with hepatitis B antigen encapsulated into alginate-coated chitosan nanoparticles 2007 ·European Journal of Pharmaceutical Sciences ·Olga Borges, Joana Tavares, Adriano de Sousa, Gerrit Borchard, Hans E. Junginger, Anabela Cordeiro‐da‐Silva	97
20	Uptake studies in rat Peyer's patches, cytotoxicity and release studies of alginate coated chitosan nanoparticles for mucosal vaccination 2006 ·Journal of Controlled Release ·Olga Borges, Anabela Cordeiro‐da‐Silva, Stefan Romeijn, Maryam Amidi, Adriano de Sousa, Gerrit Borchard, Hans E. Junginger	157

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact